EphA7 perivascular cells as myogenic and angiogenic precursors improving skeletal muscle regeneration in a muscular dystrophic mouse model.

Stem Cell Res

Department of Cardiovascular Regeneration and Innovation, Asahikawa Medical University, Asahikawa, 2-1-1 Midorigaoka-higashi, Asahikawa 078-8510, Japan; Department of Biochemistry, Asahikawa Medical University, Asahikawa, 2-1-1 Midorigaoka-higashi, Asahikawa 078-8510, Japan. Electronic address:

Published: July 2020

AI Article Synopsis

  • Skeletal muscle can regenerate through satellite cells and other non-satellite cells, but the role of non-satellite cells is not fully understood.
  • This study focuses on capillary stem cells (CapSCs) and their potential to enhance muscle regeneration in a mouse model of muscular dystrophy, showing that they outperform other cell types in myogenic activity.
  • Transplantation of CapSCs into injured muscle resulted in significant improvements, including increased muscle fiber formation, enhanced dystrophin expression, and better overall muscle performance compared to control groups, suggesting their potential as a treatment for muscular dystrophy.

Article Abstract

Skeletal muscle has a capacity for muscular regeneration mediated by satellite cells (SCs) and non-SCs. Although it is proposed that non-SCs are attractive therapeutic targets for dystrophies, the biological properties of these cells remain unclear. We have recently identified novel multipotent pericytes (PCs), capillary stem cells (CapSCs) derived from the microvasculature. In the present study, we determined if CapSCs contributed to myogenic regeneration using muscular dystrophy mouse model. CapSCs were isolated as EphA7NG2PCs from the subcutaneous adipose tissues of GFP-transgenic mice. Co-culture with C2C12 myoblast cells showed that CapSCs effectively enhanced myogenesis as compared to controls including EphA7 PCs and adipose stromal cells (ASCs). CapSCs transplanted in cardiotoxin-injured gastrocnemius muscles were well differentiated into both muscle fibers and microvessels, as compared to controls. At three weeks after cell-transplantation into the limbs of the mdx/utrnmouse, CapSCs increased the number of GFPmyofibers along with dystrophin expression and the area size of myofibers, and also enhanced the muscular mass and its performance, assessed by treadmill test as compared to controls. In conclusion, CapSCs have potent myogenic regeneration capacity and improved the pathological condition in a muscular dystrophy mouse. Thus, CapSCs are an attractive cellular source in regenerative therapy for muscular dystrophy.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.scr.2020.101914DOI Listing

Publication Analysis

Top Keywords

muscular dystrophy
12
compared controls
12
skeletal muscle
8
regeneration muscular
8
mouse model
8
capscs
8
cells capscs
8
myogenic regeneration
8
dystrophy mouse
8
cells
6

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!